Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven I&g 4 Regulatory News (MAV4)

Share Price Information for Maven I&g 4 (MAV4)

Share Price is delayed by 15 minutes
Get Live Data
50.00    0.00 (0.00%)
Bid:
49.00
Ask:
51.00
Spread: 2.00 (4.082%)
Market Cap: £83.71m
MAV4 Live PriceLast checked at - London Stock Exchange

Intraday Maven I&g 4 Share Chart

Interim Management Statement

18 Nov 2013 14:35

RNS Number : 3098T
Maven Income & Growth VCT 4 PLC
18 November 2013
 

Interim Management Statement

 

Maven Income and Growth VCT 4 PLC (the Company) - quarter ended 30 September 2013

 

This Interim Management Statement, for the quarter ended 30 September 2013, is provided in accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority and also includes relevant information in respect of the period from 1 October 2013 to the date of issue. This Statement has been prepared solely to provide additional information in order to meet the relevant requirements of the UK Listing Authority's Disclosure and Transparency Rules, and should not be relied on by Shareholders, or any other party, for any other purpose.

 

1.

Financial highlights

 

· Net asset value (NAV)1 of 96.00p per Ordinary Share and 101.01p per C Share at 30 September 2013, after payment of the interim dividend on the Ordinary Shares, compared to 97.60p and 98.40p per share respectively at 30 June 2013;

· NAV total return2 of 125.3p per Ordinary Share at 30 September 2013, compared to 124.9p at 30 June 2013; and

· Interim dividend of 2.00p per Ordinary Share in respect of the year ending 31 December 2013, paid on 27 September 2013.

 

1The NAV is unaudited and reflects the closing bid price of quoted securities at 30 September 2013. Unlisted companies are normally valued on a six-monthly basis and the NAV incorporates the Directors' valuation of unlisted investments as at 30 June 2013, adjusted for subsequent events where appropriate.

2NAV total return is the sum of NAV per share and dividends paid per share since launch.

 

2.

Investments and disposals

 

During the quarter ended 30 September 2013, a net amount of £139,826 was invested from the Ordinary Share portfolio in two unlisted companies; net proceeds of £402,967 were realised from the sale of short-dated UK treasury bills; a total of £432,553 of capital was returned from three unlisted companies against a cost of £508,811 and the full or partial disposals of four AIM quoted investments generated aggregate proceeds of £115,584 against a total cost of £103,855.

 

During the same period, the full or partial disposals of three AIM quoted investments from the C Share portfolio, generated aggregate proceeds of £48,118 against a total cost of £29,277.

 

3.

Recent developments

 

Between 1 October 2013 and the date of this Statement, £132,769 was invested in two unlisted companies; a total of £295,254 of capital was returned by two unlisted companies; and the partial disposal of an AIM quoted investment generated proceeds of £35,438 against a cost of £32,284.

 

In the same period, an investment of £112,000 in an unlisted company was made on behalf of the C Share portfolio and the sale of the unlisted investment in Espresso Group generated proceeds of £1,246,191. While the reduction of £253,809 against the carrying value of Espresso Group represents 6.5% of the net assets attributable to the C shares as at 30 September 2013, the Manager has taken the view that this was the optimum opportunity to secure an exit from a legacy investment acquired from the merger of the Company with Ortus VCT PLC earlier in 2013.

 

Other than as described above, and changes in the value of investments quoted on regulated markets, the Board is not aware of any material events during the period from 1 July 2013 to 30 September 2013, or in the period from 1 October 2013 to the date of this announcement, which would have had a material impact on the financial position of the Company.

 

Issued on behalf of the Board

 

Maven Capital Partners UK LLP

Secretary

 

18 November 2013

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSUWOSROOAAAAA
Date   Source Headline
2nd Oct 202012:41 pmRNSIssue of Equity
29th Sep 20204:49 pmRNSStatement re Dividend Investment Scheme
1st Sep 20204:35 pmRNSTransaction in Own Shares
28th Aug 20202:38 pmRNSHalf-year Report
26th Aug 20205:26 pmRNSTransaction in Own Shares
20th Aug 202011:38 amRNSStatement re NAV, Interim Dividend and DIS
20th Aug 202011:29 amRNSDirector Declaration
9th Jul 202010:00 amRNSIssue of Equity
8th Jun 20209:36 amRNSAllotment Update
21st May 202012:17 pmRNSResult of AGM
15th May 20204:10 pmRNSNet Asset Value(s)
7th May 20204:35 pmRNSPublication of Suppl.Prospcts
21st Apr 20206:24 pmRNSAnnual Financial Report
8th Apr 20203:56 pmRNSStatement re Offer for Subscription
26th Mar 20205:25 pmRNSUpdate on Net Asset Value
26th Mar 20205:00 pmRNSAllotment Update and Suspension of DIS
20th Mar 20204:57 pmRNSTransaction in Own Shares
28th Feb 20204:56 pmRNSTransaction in Own Shares
24th Feb 20204:35 pmRNSStatement re Net Asset Value and Proposed Dividend
11th Feb 20205:04 pmRNSDirector/PDMR Shareholding
11th Feb 20205:02 pmRNSDirector/PDMR Shareholding
11th Feb 20204:24 pmRNSIssue of Equity
6th Feb 20203:39 pmRNSStatement re Offer for Subscription
18th Dec 20192:14 pmRNSDirectorate Change
18th Dec 20192:09 pmRNSMerger Update: Approval of Scheme
10th Dec 201912:30 pmRNSResult of General Meeting
14th Nov 20196:20 pmRNSStatement re Offer for Subscription
14th Nov 20196:20 pmRNSStatement re Proposed Merger
7th Nov 20192:11 pmRNSNet Asset Value(s)
4th Oct 201911:30 amRNSDirector/PDMR Shareholding
4th Oct 201910:22 amRNSIssue of Equity
1st Oct 201912:34 pmRNSNet Asset Value(s)
20th Sep 201912:44 pmRNSHalf-year Report
19th Sep 20193:46 pmRNSTransaction in Own Shares
17th Sep 20193:00 pmRNSTransaction in Own Shares
28th Aug 20192:59 pmRNSStatement re Possible Merger
27th Aug 20194:38 pmRNSStatement re NAV and Interim Dividend
23rd Aug 20194:23 pmRNSStatement re Intended Joint Offer for Subscription
21st Aug 20194:14 pmRNSStatement re share premium account cancellation
21st May 20194:04 pmRNSTransaction in Own Shares
15th May 20195:02 pmRNSNet Asset Value(s)
15th May 20192:08 pmRNSResult of AGM
5th Apr 20193:25 pmRNSAnnual Financial Report
12th Mar 20192:52 pmRNSTransaction in Own Shares
28th Feb 20194:03 pmRNSNet Asset Value(s)
4th Dec 20184:42 pmRNSTransaction in Own Shares
27th Nov 20183:15 pmRNSTransaction in Own Shares
22nd Nov 20183:14 pmRNSTransaction in Own Shares
19th Nov 201811:45 amRNSDirector/PDMR Shareholding
19th Nov 201811:43 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.